Consequently, the F2P Score was established based on the combination of six genomic variables (ESR1, PGR, CD68, BAG1, BCL2, and GSTM1) and two clinicopathological variables (age and categorical tumor size) with the shrinkage factors of 0.314 and 0.888, respectively. This evidence concerns the gene BCL2 and neoplasm.